Histone Deacetylase Inhibitors as Cancer Therapeutics Advances in Cancer Research Series
Langue : Anglais
Auteur : Grant Steven
Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. This thematic volume looks at "Histone Deacetylase Inhibitors as Cancer Therapeutics."
- Histone Deacetylase Inhibitors Disrupt the Mitotic Spindle Assembly Checkpoint by Targeting Histone and Non-Histone Proteins
- Mechanisms of Resistance to Histone Deacetylase Inhibitors
- HDAC Inhibitors: Roles of DNA Damage and Repair
- HDAC Inhibitor Modulation of Proteotoxicity as a Therapeutic Approach in Cancer
- Intrinsic and Extrinsic Apoptotic Pathway Signaling as Determinants of Histone Deacetylase Inhibitor Anti-Tumor Activity
- Histone Deacetylase Inhibitors and Rational Combination Therapies
- HDAC Inhibitors and Chaperone Function
Researchers and students in the basic and clinical sciences of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology, and molecular biology.
- Provides invaluable information on the exciting and fast-moving field of cancer research
- This thematic volume looks at "Histone Deacetylase Inhibitors as Cancer Therapeutics"
- Outstanding and original reviews
Date de parution : 12-2012
Ouvrage de 288 p.
15x22.8 cm
Thème de Histone Deacetylase Inhibitors as Cancer Therapeutics :
© 2024 LAVOISIER S.A.S.